SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
282Here are the corresponding Natrecor numbers, FWIW: <i>In the seven NATRECBiomaven-9/6/2005
281Phase 2 Ularitide Study Highlighted at European Society of Cardiology Congress Snigel bates-9/4/2005
280chuckle. (eom)scaram(o)uche-8/3/2005
279Charly Travers 1; Stephen Simpson 0 ... Message 21566028nigel bates-8/3/2005
278>>Protein Design's Broad Pipeline To Drive Growth 06.23.05, 3:34 PM Etuck-6/23/2005
277Protein Design Labs Sublicenses Rights to Develop Antibody-Drug Conjugates for Pnigel bates-6/22/2005
276More Avastin colour - Message 21323547nigel bates-5/14/2005
275SAN FRANCISCO (MarketWatch) - Biotechnology stocks edged up Tuesday morning aftenigel bates-4/26/2005
274Protein Design Labs and Orphan Therapeutics Report Fast Track Designation for Tesjemmeri-4/20/2005
273Press Release Source: Protein Design Labs, Inc. Protein Design Labs Reports Postnsaf-4/18/2005
272Seattle Genetics In-licenses Anti-CD33 Antibody Program from Protein Design Labsnigel bates-4/13/2005
271Protein Design Labs Reports on Nuvion(R) (Visilizumab) End of Phase I Meeting Henigel bates-3/23/2005
270Your chance to vote now for Charly T (and PDLI)... fool.com (Putting my mouth nigel bates-3/22/2005
269Protein Design Labs Announces Above Consensus Full-Year and Fourth Quarter 2004 nigel bates-3/15/2005
268<i>I hate it when companies quote bogus/self serving statistics: makes susnigel bates-2/9/2005
267Protein Design Labs Announces Intent to Offer $250 Million of Convertible Seniornigel bates-2/9/2005
266Protein Design Labs Announces Ruling in European Patent Opposition Proceeding Wenigel bates-2/2/2005
265PDL to Adjust Purchase Price for ESP Pharma, Inc. Following ESP Pharma's Acqnigel bates-2/2/2005
264SSB: pdli HOLD (2)mopgcw-1/27/2005
263SSB: Protein Design Labs (PDLI, Hold, Speculative) Reporting date: Tentative dmopgcw-1/27/2005
262PDL to Acquire ESP Pharma, Inc. FREMONT, Calif. and EDISON, N.J., Jan. 25 /PRNenigel bates-1/25/2005
261PDL Updates Status of Clinical Development Programs and Partnering Objectives Wenigel bates-1/12/2005
260Standard & Poor's Equity Research upgraded Protein Design (nasdaq: PDLI)nigel bates-12/8/2004
259Protein Design Labs Enters Agreement to Access Cyntellect's Cell Xpress(TM) nigel bates-10/26/2004
258Last year's deal looking pretty good - siliconinvestor.com <i>Under tnigel bates-9/16/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News